Skip to main content

Closed

SCYX: SCYNEXIS, Inc. Stock Analysis | finqOS

Healthcare · Medical - Pharmaceuticals

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+449.9% / yr

Operating margin-119.9%

ROIC-39.2%

Financially safe

Stretched

Debt / equity0.05×

Interest coverage0.0×

Current ratio3.94×

SCYNEXIS, Inc.

SCYXNASDAQ·USD·Closed

SCYNEXIS, Inc.

SCYXNASDAQ·USD·Closed

$4.84

+29.76%

$4.84

+$1.11 (29.76%)

52W Range

19thpctl

Volume

44.27×avg

Mkt Cap

30.44MUSD

P/E

-1.4TTM

Div Yield

–ann

52W Range

19thpctl

Volume

44.27×avg

Market Cap

30.44MUSD

P/E Ratio

-1.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings